Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * KEANE JOHN M 2. Date of Event Requiring Statement (Month/Day/Year) 08/19/2025 3. Issuer Name and Ticker or Trading Symbol UNITED STATES ANTIMONY CORP [UAMY] (Last) (First) (Middle) 4438 W LOVERS LANE, UNIT 100 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) DALLAS, TX 75209 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 0 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock	(1)	(1)	Common Stock	68,200(1)	$0	D
Stock Options	(2)	08/19/2035	Common Stock	34,100(2)	$4.26	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
KEANE JOHN M 4438 W LOVERS LANE, UNIT 100 DALLAS, TX 75209	X

Signatures

/s/ John M. Keane		10/06/2025
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on August 19, 2025 under the Issuer's Amended and Restated 2023 Equity Incentive Plan. One-third, or 22,733 shares of the 68,200 total number of shares, of the RSU award will vest on August 19, 2026 and an additional one-third of the total number of shares will vest on August 19, 2027 and August 19, 2028 subject to the Reporting Person's continued service through each vesting date.
(2)	Represents shares of Common Stock underlying a time-based vesting stock option award granted on August 19, 2025 under the Issuer's Amended and Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 11,367 shares of the 34,100 total number of shares on August 19, 2026 and an additional one-third of the total number of shares will vest on August 19, 2027 and August 19, 2028, subject to the Reporting Person's continued service through any vesting date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.